{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:55:48Z","timestamp":1761267348170,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.hpb.2023.10.004","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T19:08:22Z","timestamp":1697051302000},"page":"179-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A critical appraisal of the potential benefit of post-operative structured follow-up after resection for biliary tract cancer"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-4637","authenticated-orcid":false,"given":"Lynn E.","family":"Nooijen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizzel","family":"van der Snee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britte","family":"ten Haaft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"Kazemier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7290-1823","authenticated-orcid":false,"given":"Heinz-Josef","family":"Kl\u00fcmpen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Bridgewater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Primrose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8233-1505","authenticated-orcid":false,"given":"Joris","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl.\u00a01","key":"10.1016\/j.hpb.2023.10.004_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/liv.14089","article-title":"Surgery for cholangiocarcinoma","volume":"39","author":"Cillo","year":"2019","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.hpb.2023.10.004_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jhep.2021.12.010","article-title":"Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry","volume":"76","author":"Izquierdo-Sanchez","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.hpb.2023.10.004_bib3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jamcollsurg.2015.09.005","article-title":"Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection","volume":"221","author":"Groot Koerkamp","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2023.10.004_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","article-title":"Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection","volume":"23","author":"Spolverato","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib5","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.surg.2012.12.005","article-title":"Recurrence after operative management of intrahepatic cholangiocarcinoma","volume":"153","author":"Hyder","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.10.004_bib6","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1245\/s10434-020-08534-2","article-title":"Time to recurrence after surgical resection and survival after recurrence among patients with perihilar and distal cholangiocarcinomas","volume":"27","author":"Nakanishi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib7","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1007\/s00268-018-4530-0","article-title":"Defining early recurrence of hilar cholangiocarcinoma after curative-intent surgery: a multi-institutional study from the US Extrahepatic Biliary Malignancy Consortium","volume":"42","author":"Zhang","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.hpb.2023.10.004_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1457496919832150","article-title":"Differences in prognostic factors and recurrence patterns after curative-intent resection of perihilar and distal cholangiocarcinomas","volume":"109","author":"Sallinen","year":"2020","journal-title":"Scand J Surg"},{"key":"10.1016\/j.hpb.2023.10.004_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jjco\/hyw182","article-title":"Survival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature","volume":"47","author":"Miyazaki","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib10","first-page":"Jco2102568","article-title":"Long-term outcomes and exploratory analyses of the randomized phase III BILCAP study","author":"Bridgewater","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.surg.2017.08.011","article-title":"Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach","volume":"163","author":"Komaya","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.10.004_bib12","article-title":"Systematic review and meta-analysis of prognostic factors for early recurrence in intrahepatic cholangiocarcinoma after curative-intent resection","author":"Choi","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib13","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.surg.2020.04.068","article-title":"How long should follow-up be continued after R0 resection of perihilar cholangiocarcinoma?","volume":"168","author":"Nakahashi","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.10.004_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1245\/s10434-020-09108-y","article-title":"Defining and predicting early recurrence after resection for gallbladder cancer","volume":"28","author":"Sahara","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hpb.2016.05.016","article-title":"Rates and patterns of recurrence after curative intent\u00a0resection\u00a0for gallbladder cancer: a multi-institution analysis from\u00a0the US Extra-hepatic Biliary Malignancy Consortium","volume":"18","author":"Margonis","year":"2016","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2023.10.004_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.hpb.2023.10.004_bib20","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.1097\/SLA.0000000000005378","article-title":"An international multicenter study exploring whether surveillance after esophageal cancer surgery impacts oncological and quality of life outcomes (ENSURE)","volume":"277","author":"Elliott","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.10.004_bib21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/annonc\/mdu543","article-title":"Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis","volume":"26","author":"Pita-Fern\u00e1ndez","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib22","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ejso.2015.06.008","article-title":"Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: results of the randomized \u201cCEAwatch\u201d trial","volume":"41","author":"Verberne","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib23","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ejso.2021.03.235","article-title":"No benefit of more intense follow-up after surgery for colorectal cancer in the risk group with elevated CEA levels \u2013 an analysis within the COLOFOL randomized clinical trial","volume":"47","author":"Egenvall","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2023.10.004_bib24","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s10120-017-0751-4","article-title":"Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis","volume":"21","author":"Sisic","year":"2018","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.hpb.2023.10.004_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-015-1498-0","article-title":"Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) \u2013 a randomized, multidisciplinary, multinational phase III trial","volume":"15","author":"Stein","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2023.10.004_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2468-1253(19)30004-4","article-title":"Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2\/3 trial","volume":"4","author":"van Hilst","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2023.10.004_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12885-021-08031-z","volume":"21","author":"Janssen","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2023.10.004_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)15383-4","article-title":"Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review","volume":"363","author":"Peppercorn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.hpb.2023.10.004_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12885-020-06916-z","article-title":"Are cancer patients better off if they participate in clinical trials? A mixed methods study","volume":"20","author":"Engelbak Nielsen","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hpb.2023.10.004_bib30","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2023.10.004_bib31","doi-asserted-by":"crossref","first-page":"298985","DOI":"10.1155\/2015\/298985","article-title":"Postoperative CA19-9 change is a useful predictor of intrahepatic cholangiocarcinoma survival following liver resection","volume":"2015","author":"Yoo","year":"2015","journal-title":"Dis Markers"},{"key":"10.1016\/j.hpb.2023.10.004_bib32","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.21873\/anticanres.12931","article-title":"Relationship between CA 19.9 and the Lewis phenotype: options to improve diagnostic efficiency","volume":"38","author":"Parra-Robert","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hpb.2023.10.004_bib33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.21873\/anticanres.13216","article-title":"Serum CA 19.9 levels in patients with benign and malignant disease: correlation with the serum protein electrophoretic pattern","volume":"39","author":"Gund\u00edn-Men\u00e9ndez","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hpb.2023.10.004_bib34","doi-asserted-by":"crossref","first-page":"8820","DOI":"10.1038\/s41598-020-65720-8","article-title":"Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.hpb.2023.10.004_bib35","first-page":"1804","article-title":"Differential\u00a0diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant","volume":"9","author":"Liu","year":"2018","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.hpb.2023.10.004_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14102389","article-title":"Impact of positive lymph nodes and resection margin status on the overall survival of patients with resected perihilar cholangiocarcinoma: the ENSCCA registry","volume":"14","author":"Nooijen","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.hpb.2023.10.004_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051379","article-title":"State of the art: ctDNA in upper gastrointestinal malignancies","volume":"15","author":"Labiano","year":"2023","journal-title":"Cancers"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X23019445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X23019445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:43:53Z","timestamp":1761266633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X23019445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1365182X23019445"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2023.10.004","relation":{},"ISSN":["1365-182X"],"issn-type":[{"type":"print","value":"1365-182X"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical appraisal of the potential benefit of post-operative structured follow-up after resection for biliary tract cancer","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2023.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of International Hepato-Pancreato-Biliary Association Inc.","name":"copyright","label":"Copyright"}]}}